Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Sold by Courier Capital LLC

Courier Capital LLC decreased its position in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 65.2% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 7,285 shares of the medical research company’s stock after selling 13,629 shares during the quarter. Courier Capital LLC’s holdings in Thermo Fisher Scientific were worth $3,625,000 as of its most recent filing with the SEC.

Other institutional investors have also bought and sold shares of the company. Bernard Wealth Management Corp. acquired a new stake in Thermo Fisher Scientific during the 4th quarter worth about $25,000. FPC Investment Advisory Inc. bought a new stake in Thermo Fisher Scientific during the fourth quarter worth approximately $28,000. Pillar Financial Advisors LLC bought a new stake in Thermo Fisher Scientific during the fourth quarter worth approximately $29,000. Ameriflex Group Inc. bought a new stake in shares of Thermo Fisher Scientific in the fourth quarter valued at approximately $30,000. Finally, Noble Wealth Management PBC bought a new stake in shares of Thermo Fisher Scientific in the fourth quarter valued at approximately $35,000. Institutional investors and hedge funds own 89.23% of the company’s stock.

Insider Buying and Selling

In related news, EVP Gianluca Pettiti sold 300 shares of the business’s stock in a transaction on Monday, April 28th. The stock was sold at an average price of $429.93, for a total transaction of $128,979.00. Following the sale, the executive vice president now owns 23,167 shares in the company, valued at $9,960,188.31. The trade was a 1.28% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. 0.33% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

TMO has been the subject of a number of recent research reports. Wall Street Zen upgraded Thermo Fisher Scientific from a “hold” rating to a “buy” rating in a research note on Wednesday, May 21st. The Goldman Sachs Group set a $610.00 target price on Thermo Fisher Scientific and gave the company a “buy” rating in a research note on Wednesday, April 23rd. Evercore ISI cut their target price on Thermo Fisher Scientific from $585.00 to $500.00 and set an “outperform” rating for the company in a research note on Thursday, April 24th. Robert W. Baird dropped their price objective on Thermo Fisher Scientific from $603.00 to $573.00 and set an “outperform” rating for the company in a research note on Thursday, April 24th. Finally, Wells Fargo & Company dropped their price objective on Thermo Fisher Scientific from $580.00 to $570.00 and set an “overweight” rating for the company in a research note on Thursday, April 24th. Four research analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $605.30.

Thermo Fisher Scientific Price Performance

Shares of NYSE TMO opened at $401.99 on Monday. The stock has a market capitalization of $151.75 billion, a PE ratio of 24.32, a P/E/G ratio of 2.99 and a beta of 0.78. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.66 and a quick ratio of 1.29. The business has a fifty day moving average price of $420.74 and a two-hundred day moving average price of $495.68. Thermo Fisher Scientific Inc. has a fifty-two week low of $390.50 and a fifty-two week high of $627.88.

Thermo Fisher Scientific (NYSE:TMO) last issued its quarterly earnings results on Wednesday, April 23rd. The medical research company reported $5.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.10 by $0.05. Thermo Fisher Scientific had a return on equity of 17.51% and a net margin of 14.78%. The company had revenue of $10.36 billion for the quarter, compared to analyst estimates of $10.23 billion. During the same quarter last year, the company posted $5.11 EPS. The company’s revenue for the quarter was up .2% compared to the same quarter last year. As a group, equities analysts predict that Thermo Fisher Scientific Inc. will post 23.28 earnings per share for the current fiscal year.

Thermo Fisher Scientific Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, July 15th. Investors of record on Friday, June 13th will be given a dividend of $0.43 per share. The ex-dividend date is Friday, June 13th. This represents a $1.72 dividend on an annualized basis and a yield of 0.43%. Thermo Fisher Scientific’s dividend payout ratio is currently 10.09%.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.